Literature DB >> 27029851

Intravenous amoxicillin/clavulanate for the prevention of bacteraemia following dental procedures: a randomized clinical trial.

J Limeres Posse1, M Álvarez Fernández2, J Fernández Feijoo3, J Medina Henríquez4, P B Lockhart5, V H Chu6, P Diz Dios7.   

Abstract

OBJECTIVES: Although controversy exists regarding the efficacy of antibiotic prophylaxis for patients at risk of infective endocarditis, expert committees continue to publish recommendations for antibiotic prophylaxis regimens. This study aimed to evaluate the efficacy of four antimicrobial regimens for the prevention of bacteraemia following dental extractions.
METHODS: The study population included 266 adults requiring dental extractions who were randomly assigned to the following five groups: control (no prophylaxis); 1000/200 mg of amoxicillin/clavulanate intravenously; 2 g of amoxicillin by mouth; 600 mg of clindamycin by mouth; and 600 mg of azithromycin by mouth. Venous blood samples were collected from each patient at baseline and at 30 s, 15 min and 1 h after dental extractions. Samples were inoculated into BACTEC Plus culture bottles and processed in the BACTEC 9240. Conventional microbiological techniques were used for subcultures and further identification of the isolated bacteria. The trial was registered at ClinicalTrials.gov with ID number NCT02115776.
RESULTS: The incidence of bacteraemia in the control, amoxicillin/clavulanate, amoxicillin, clindamycin and azithromycin groups was: 96%, 0%, 50%, 87% and 81%, respectively, at 30 s; 65%, 0%, 10%, 65% and 49% at 15 min; and 18%, 0%, 4%, 19% and 18% at 1 h. Streptococci were the most frequently identified bacteria. The percentage of positive blood cultures at 30 s post-extraction was lower in the amoxicillin/clavulanate group than in the amoxicillin group (P < 0.001). The incidence of bacteraemia in the clindamycin group was similar to that in the control group.
CONCLUSIONS: Bacteraemia following dental extractions was undetectable with amoxicillin/clavulanate prophylaxis. Alternative antimicrobial regimens should be sought for patients allergic to the β-lactams.
© The Author 2016. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27029851     DOI: 10.1093/jac/dkw081

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  7 in total

1.  Prevention of serious infections in hereditary hemorrhagic telangiectasia: roles for prophylactic antibiotics, the pulmonary capillaries-but not vaccination.

Authors:  Claire Shovlin; Kathleen Bamford; Carlo Sabbà; Hans-Jurgen Mager; Anette Kjeldsen; Freya Droege; Elisabetta Buscarini; Sophie Dupuis-Girod
Journal:  Haematologica       Date:  2019-02       Impact factor: 9.941

Review 2.  Antibiotic prophylaxis before dental procedures to prevent infective endocarditis: a systematic review.

Authors:  Judith Bergadà-Pijuan; Michelle Frank; Sara Boroumand; Frédérique Hovaguimian; Carlos A Mestres; Robert Bauernschmitt; Thierry Carrel; Bernd Stadlinger; Frank Ruschitzka; Annelies S Zinkernagel; Roger D Kouyos; Barbara Hasse
Journal:  Infection       Date:  2022-08-16       Impact factor: 7.455

3.  Whole genome sequences discriminate hereditary hemorrhagic telangiectasia phenotypes by non-HHT deleterious DNA variation.

Authors:  Katie E Joyce; Ebun Onabanjo; Sheila Brownlow; Fadumo Nur; Kike Olupona; Kehinde Fakayode; Manveer Sroya; Geraldine A Thomas; Teena Ferguson; Julian Redhead; Carolyn M Millar; Nichola Cooper; D Mark Layton; Freya Boardman-Pretty; Mark J Caulfield; Claire L Shovlin
Journal:  Blood Adv       Date:  2022-07-12

4.  Is clindamycin effective in preventing infectious complications after oral surgery? Systematic review and meta-analysis of randomized controlled trials.

Authors:  Iciar Arteagoitia; Fabio Rodríguez Sánchez; Amaia Figueras; Nagore Arroyo-Lamas
Journal:  Clin Oral Investig       Date:  2022-03-02       Impact factor: 3.606

5.  European Reference Network For Rare Vascular Diseases (VASCERN) Outcome Measures For Hereditary Haemorrhagic Telangiectasia (HHT).

Authors:  Claire L Shovlin; Elisabetta Buscarini; Anette D Kjeldsen; Hans Jurgen Mager; Carlo Sabba; Freya Droege; Urban Geisthoff; Sara Ugolini; Sophie Dupuis-Girod
Journal:  Orphanet J Rare Dis       Date:  2018-08-15       Impact factor: 4.123

6.  Impact of the COVID-19 Pandemic on Antibiotic Prescribing by Dentists in Galicia, Spain: A Quasi-Experimental Approach.

Authors:  Almudena Rodríguez-Fernández; Olalla Vázquez-Cancela; María Piñeiro-Lamas; Adolfo Figueiras; Maruxa Zapata-Cachafeiro
Journal:  Antibiotics (Basel)       Date:  2022-07-29

7.  Cerebral Abscess Associated With Odontogenic Bacteremias, Hypoxemia, and Iron Loading in Immunocompetent Patients With Right-to-Left Shunting Through Pulmonary Arteriovenous Malformations.

Authors:  Emily J Boother; Sheila Brownlow; Hannah C Tighe; Kathleen B Bamford; James E Jackson; Claire L Shovlin
Journal:  Clin Infect Dis       Date:  2017-08-15       Impact factor: 9.079

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.